Cold Plasma Market by Pressure, Application, by End-User, and By Region

The global Cold Plasma Market size was estimated to be USD 129.4 Million in 2023 and is expected to reach USD 657.2 Million by 2034 with a CAGR of 15.92% during the forecast period 2024-2034. The global cold plasma market is predominantly driven by a multifaceted interplay of increasing demand for non-thermal sterilization technologies, heightened food safety concerns, and significant advancements in medical applications. The efficacy of cold plasma in providing a non-thermal alternative for sterilization positions it favorably across sectors such as healthcare and food processing, where traditional methods may cause harm to sensitive materials.

​A vital driver of growth in the global cold plasma market is the ongoing technological advancement, which broadens its applicability across various sectors, especially in healthcare. In February 2024, Adtec Healthcare visited Taiwan to further its SteriPlas expansion project, with a specific focus on enhancing cold plasma technology for sterilization applications. This initiative strategically aims to strengthen Adtec's presence in the Asian market while addressing the escalating demand for innovative healthcare solutions. The expansion underscores the company's commitment to elevating healthcare standards through the implementation of advanced sterilization techniques and forging strategic technology partnerships.

By pressure, the atmospheric pressure cold plasma segment accounted for the highest revenue-grossing segment in the global Cold Plasma Market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the increased adoption in medical and healthcare applications, including wound healing, cancer treatment, and sterilization processes, as well as its widespread use in surface treatment across industries like textiles, food packaging, and electronics due to its cost-effectiveness, operational efficiency, and ability to operate without the need for vacuum systems. In May 2024, US Medical Innovations, LLC (USMI) acquired FDA 510k clearance (K240297) for the Canady Helios Cold Plasma™ (CHCP) Ablation System. This system is used to ablate soft tissue during surgery. The CHCP system includes the Canady Helios Cold Plasma XL-1000 CP Smart Electrosurgical Generator, Canady Helios Cold Plasma Ablators, Foot Pedal, and Trolley Cart.

By application, the surface treatment segment accounted for the highest revenue-grossing segment in the global Cold Plasma Market in 2023 owing to the widespread use of cold plasma for enhancing material properties such as adhesion, wettability, and surface cleaning across industries like electronics, automotive, textiles, and polymers, as well as its eco-friendly and efficient nature compared to traditional chemical-based surface modification techniques. For instance, in September 2023, researchers at IIT Jodhpur developed the Novel Cold-Plasma Detergent in Environment (CODE) device, which aims to improve indoor air quality by deactivating over 99.99% of dangerous microorganisms. This device solves major air pollution concerns, notably indoors. The CODE device, which uses non-equilibrium cold plasma and nanotechnology, promises to minimize airborne diseases and is scheduled for commercial distribution soon. Additionally, the wound healing segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for advanced and non-invasive treatment options, the rising prevalence of chronic wounds such as diabetic ulcers and pressure sores, and the growing adoption of cold plasma technology for its ability to promote faster healing, reduce infection risks, and improve patient outcomes without the use of antibiotics or harmful chemicals.

By end-user, the hospital segment accounted for the highest revenue-grossing segment in the global Cold Plasma Market in 2023 owing to the extensive use of cold plasma technology for sterilization of medical instruments, disinfection of surfaces, and its growing application in wound healing and dermatological treatments, driven by increasing healthcare infrastructure investments and the rising demand for advanced, non-invasive medical technologies. For instance, Relyon Plasma stated in January 2023 that the PZ3-i piezobrush will soon feature a CAN-Bus Interface, which will enhance its functionality. The PZ3-i cold plasma unit is a small, safe, and efficient piezobrush that can be easily included into both modern and traditional production lines. It works particularly well as a pre-treatment for bonding, printing, and laminating processes, guaranteeing process and product quality simultaneously. Additionally, the specialty clinics segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for specialized treatments such as dermatology and wound care, the increasing adoption of cold plasma technology for non-invasive procedures, and the growing focus on providing advanced therapeutic solutions for skin conditions, chronic wounds, and cosmetic treatments in dedicated healthcare settings

North American region is anticipated to have the highest revenue share during the forecast period owing to the strong presence of advanced healthcare infrastructure, increased investment in medical technology, widespread adoption of cold plasma in industries such as healthcare, electronics, and food packaging, as well as favorable government initiatives and a growing focus on non-invasive treatment options and environmental sustainability. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapid industrialization, increasing investments in healthcare infrastructure, rising awareness of advanced medical technologies, and growing applications of cold plasma in agriculture and food processing, combined with a rising population and demand for effective wound care and sterilization solutions. For instance, in June 2023, Plasmatreat GmbH, a pioneer in atmospheric plasma technology and systems research and manufacturing, developed a range of equipment and surface-treatment procedures based on plasma systems and open-air plasma processes. Precise "open-air" compressed air and electricity are used to apply plasma to the substrate using a specialized nozzle.

This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.

Report Scope:

• Base Year: 2023
• Forecast Period: 2024-2034
• Study Coverage
• Market Forecast by Pressure, Application, and End-User
• Market Forecast for 5 Regions and 17+ Countries
• North America (U.S. and Canada)
• Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
• Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
• Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
• MEA (South Africa, GCC, Rest of MEA)
• Exhaustive Company Profiles of the Top 10+ Major Market Players
• 20% Free Customization Available to Meet Your Exact Requirement.

Segmentation: Cold Plasma Market Report 2023 - 2034

Cold Plasma Market Analysis & Forecast by Pressure 2023 - 2034 (Revenue USD Mn)

• Low-Pressure Cold Plasma
• Atmospheric Pressure Cold Plasma

Cold Plasma Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Mn)

• Adhesion
• Sterilization and Disinfection
• Etching
• Decontamination
• Surface Treatment
• Coating
• Finishing
• Printing
• Wound Healing
• Blood Coagulation
• Dentistry
• Cancer Treatment
• Other Medical Applications

Cold Plasma Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Mn)

• Hospital
• Specialty Clinics
• Textile Industry
• Others

Cold Plasma Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of LATAM
• Middle East & Africa
• South Africa
• GCC
• Rest of MEA